4th Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Firm
Client
Income
—
Expenses
$76,358
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FY-2014 Appropriations Continuing Resolution ; Inclusion of anomalies for funding for Biomedical Advanced Research and Development Authority (BARDA) and funding for Project BioShield Special Reserve Fund (SRF) to fund medical countermeasure procurement in the Startegic National Stockpile. Funding for biodefense (BARDA/SRF) in the FY-2014 Appropriations Act.

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP Policy and Government Affairs
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.